New evidence-based clinical practice guidelines to address peripartum depression

Pfiz­er’s new cer­vi­cal can­cer drug Tiv­dak has been con­vert­ed from an ac­cel­er­at­ed to a full ap­proval. The Seagen and Gen­mab-parterned drug, al­so known as ti­so­tum­ab ve­dotin-tftv,

(This sto­ry is from our new Health Tech newslet­ter. If you’d like to sign up, just click here.)  Health tech’s strug­gles to raise mon­ey bled

There was a steady increase in the prevalence of chronic hypertension in pregnancy over the last two decades, with some accompanying changes in treatment, a